SCHEMBL9166194

SCHEMBL9166194

CCCCCCCCCCCCOC(=O)c1cc(C(=O)OCCCCCCCCCCCC)cc(N(CC(=O)O)CC(=O)O)c1

nearest known ligand 0.64

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 1/20 0.64
▸ BLM P54132 1/20 0.64
▸ ESR1 P03372 9/20 0.57
▸ AKR1C4 P17516 1/20 0.57
▸ AKR1C3 P42330 1/20 0.57
▸ AKR1C2 P52895 1/20 0.57
▸ AKR1C1 Q04828 1/20 0.57
▸ CNR2 P34972 2/20 0.50
▸ ALDH1A1 P00352 2/20 0.50
▸ NPC1 O15118 1/20 0.50
▸ MAPT P10636 1/20 0.50
▸ RAB9A P51151 1/20 0.50
▸ CNR1 P21554 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ LMNA P02545 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9166922 1.00 PLA2G2A (0.64) PLA2G2ABLMESR1AKR1C4AKR1C3
SCHEMBL9165915 1.00 PLA2G2A (0.64) PLA2G2ABLMESR1AKR1C4AKR1C3
SCHEMBL19406565 0.83 ESR1 (0.77) ESR1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL9355632 0.83 ESR1 (0.77) ESR1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL22289827 0.83 ESR1 (0.77) ESR1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL22289841 0.83 ESR1 (0.77) ESR1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL22289817 0.83 ESR1 (0.77) ESR1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL22289766 0.83 ESR1 (0.77) ESR1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL9165252 0.82 TSHR (0.51) PLA2G2ABLMESR1AKR1C4AKR1C3
SCHEMBL22289821 0.82 ESR1 (0.74) ESR1AKR1C4AKR1C3AKR1C2AKR1C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5446189-A Diester intermediates for diacid enzyme inhibitor HOFFMANN-LA ROCHE INC. (US) 1995-08-29 — — US disclosed
US-5324747-A Treatment of inflammatory diseases HOFFMANN-LA ROCHE INC. (US) 1994-06-28 — — US disclosed
EP-0579066-A2 N-substituted anilines F. HOFFMANN-LA ROCHE AG (CH) 1994-01-19 — — EP disclosed
Send feedback